Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Apply
AL3818
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step